CONCORD DRUGS
Back to Balance Sheet
|
CONCORD DRUGS Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Total Non-Current Assets | ₹24 Cr | ₹21 Cr | ₹15 Cr | ₹15 Cr |
What is the latest Total Non-Current Assets ratio of CONCORD DRUGS ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹24 Cr |
| Mar2024 | ₹21 Cr |
| Mar2023 | ₹15 Cr |
| Mar2022 | ₹15 Cr |
How is Total Non-Current Assets of CONCORD DRUGS Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹24 Cr | 14.52 | |
| Mar2024 | ₹21 Cr | 44.09 | |
| Mar2023 | ₹15 Cr | 1.51 | |
| Mar2022 | ₹15 Cr | - | |
Compare Total Non-Current Assets of peers of CONCORD DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD DRUGS | ₹103.3 Cr | 6.2% | -1.4% | 16.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | -0.2% | -3.2% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,531.0 Cr | 2% | 5.3% | 57.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,957.0 Cr | -2.4% | -3.1% | 36.4% | Stock Analytics | |
| CIPLA | ₹111,729.0 Cr | 0.6% | -2.2% | -9.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,335.0 Cr | 0.9% | 4% | -7.6% | Stock Analytics | |
CONCORD DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD DRUGS | 6.2% |
-1.4% |
16.9% |
| SENSEX | -2.7% |
-5.7% |
-11.7% |
You may also like the below Video Courses